Page last updated: 2024-11-04

sulfasalazine and Dacryoadenitis

sulfasalazine has been researched along with Dacryoadenitis in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
"Dacryoadenitis is the rarest form of ocular adnexal involvement in regional enteritis, which affects the orbit far more frequently than ulcerative colitis."1.40Granulomatous dacryoadenitis in regional enteritis (crohn disease). ( Jakobiec, FA; Kazim, M; Lane, KA; Rashid, A, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jakobiec, FA1
Rashid, A1
Lane, KA1
Kazim, M1

Other Studies

1 other study available for sulfasalazine and Dacryoadenitis

ArticleYear
Granulomatous dacryoadenitis in regional enteritis (crohn disease).
    American journal of ophthalmology, 2014, Volume: 158, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Biomarkers; CD8-Positive T-Lymphocytes

2014